Impax Asset Management Group plc Cuts Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Impax Asset Management Group plc lowered its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 51.9% in the third quarter, Holdings Channel reports. The institutional investor owned 1,406,625 shares of the business services provider’s stock after selling 1,518,516 shares during the period. Impax Asset Management Group plc’s holdings in Stericycle were worth $85,196,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Clearstead Trust LLC bought a new stake in Stericycle during the first quarter valued at about $25,000. International Assets Investment Management LLC bought a new stake in shares of Stericycle in the 2nd quarter valued at about $45,000. Headlands Technologies LLC purchased a new position in shares of Stericycle in the 1st quarter worth approximately $44,000. Quest Partners LLC raised its stake in shares of Stericycle by 4,172.7% during the 2nd quarter. Quest Partners LLC now owns 940 shares of the business services provider’s stock worth $55,000 after acquiring an additional 918 shares in the last quarter. Finally, Summit Securities Group LLC purchased a new stake in Stericycle during the second quarter valued at approximately $58,000. Institutional investors own 98.82% of the company’s stock.

Stericycle Stock Performance

NASDAQ SRCL opened at $61.98 on Tuesday. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $61.99. The company has a fifty day simple moving average of $60.82 and a two-hundred day simple moving average of $56.82. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. The stock has a market cap of $5.75 billion, a P/E ratio of 163.11, a P/E/G ratio of 3.38 and a beta of 1.10.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Stericycle in a report on Monday. They issued a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $74.00.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.